LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2018

Jun 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2018-06-08

Reporting Person: Tessmer James F (VP, Finance & Accounting)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-08	Common Stock	M	10000	$10.15	Acquired	35643	Direct
2018-06-08	Common Stock	S	10000	$12.9076	Disposed	25643	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-08	Stock Option (Right to Buy)	$10.15	M	10000	Disposed	2019-02-12	Common Stock (10000)	Direct

Footnotes

F1: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/12/2010) and vests 1/48th per month for each month of service thereafter.